Liên kết
ymsgr:sendim?auxeman
http://dnapharma.com.vn/GioiThieu.aspx?lang=vn&cat=15&id=56
ymsgr:sendim?phanvanvy_dna
Số lượt truy cập (hits)
 
SAFORLIV
DNA PHARMA
DESCRIPTION

    
Medicine treatment of liver Policy

COMPOSITION

    
Orthinine-L-L-aspartate ... 200mg

    
Excipients ... 1vien

    
(Microcrystalline cellulose, Croscarmellose sodium, Povidon, Magnesium stearate, Colloidal silicon dioxide)

DOSAGE

    
Tablets, box 6 blisters x 10

PRESENTATION

    
Box of 6 blisters x 10

ACTIONS

    
L-Ornithine and L-aspartate is a complex double salts, other than the drug L-Ornithine contains only normal when the body decomposes compounds into the amino acid is L-Ornithine and L-aspartate. Two amino acids are involved in material cycle and urea synthesis glutamin. Glutamin synthesis of intracellular intact is very effective means to adjust the amount of ammonia into urea cycle synthesis. Therefore, coordination and L-Ornithine L-aspartate has reciprocal effect in the process reduces the concentration of ammonia (ammonia in the blood is generated by decomposition protid, liver has the task of processing the blood ammonia urea). In addition, Ornithine and aspartate also indirectly participate in creating ATP energy to provide energy for urea synthesis and stimulates the activity of liver function. Special function of fat metabolism and reproduction of liver parenchyma. This function is important in the treatment of fatty liver infection and treatment of hepatitis.

    
Research shows that many results on many patients have been studied, the symptoms improved liver very well, just some quick men reduced the liver, fat and fiber condition markedly improved. Patients delicious, all digestive disorders, not anorexia, gone gold. Often women in the fungal inflammation of the liver or poisoning the pregnancy, so use Ornithine aspartate will bring significant results.

INDICATIONS

     
Increased blood ammonia-related liver disease with acute and chronic, cirrhosis, fatty liver infection, hepatitis ...

    
Treatment of consciousness disorder (pre-coma) or neurological complications (pathological brain liver).

CONTRAINDICATIONS

    
Hypersensitivity to other components of the drug, the severe renal impairment

PRECAUTIONS

    
Caution when using the drug for pregnant women, nursing mothers.

INTERACTIONS

    
No information.

ADVERSE

    
Rarely:

    
Nausea, vomiting, no need to stop treatment.

    
Inform your physician about having unwanted effects PAHI using drugs

DOSAGE

     
Drink 1-3 capsule 3lan/ngay after meals, the drug in 1-2 weeks.

     
Maintenance dose: 1vien x 3lan/ngay using drugs at least 4-5 weeks. Duration of treatment depends on the stage of disease.

SHELF

    
24 months from the date of manufacture

STORAGE

    
Cool dry place, protected from light.

    
Keep out of reach of children

STANDARD
    
Manufacturer

Các..sản..phẩm..khác .................................................................................................................................... [Quay về]
http://dnapharma.com.vn/GioiThieu.aspx?lang=vn&cat=15&id=56
http://dnapharma.com.vn/Products_.aspx?lang=en&cat=10&id=35
http://dnapharma.com.vn/GioiThieu.aspx?lang=en&cat=15&id=56
http://dnapharma.com.vn/Products_.aspx?lang=en&cat=13&id=23
http://dnapharma.com.vn/Products_.aspx?lang=en&cat=10&id=32
http://dnapharma.com.vn/Products_.aspx?lang=en&cat=11&id=170